Superparamagnetic nanoparticles containing liposomes as potential specific contrast agent for brain MR imaging: Initial feasibility study by a combined approach with59Fe-activated track-autoradiography

Journal of Trace and Microprobe Techniques

Volumn 16, Issue 4, 1998, Pages 523-534

  Wittendorp Rechenmann, Elisabeth ^a   Narner, Izzie J ^a   Steibel, Jérôme ^a   Lam, Dao C ^a   Pouliquen, Daniel ^b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b Universite d'Angers   (France)

Author keywords

emitters; 59Fe; Blood brain barrier; Brain; Contrast agent; Liposomes; Magnetic resonance imaging; Mannose; Micro autoradiography

Indexed keywords

EID: 0009491186     PISSN: 07334680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Barsky D, Pütz B, Schulten K, Magin RL (1992) Theory of paramagnetic contrast agents in liposome systems. Magn. Reson. Med. 24, 1-13.
2. Cerdan S, Lötscher HR, Künnecke B, Seelig J (1989) Monoclonal antibody-coated magnetite particles as contrast agents in magnetic resonance imaging of tumors. Magn. Reson. Med. 12, 151-163.
3. Josephson L, Groman EV, Menz E, Lewis JM, Bengele HH (1990) A functionalized superparamagnetic iron oxide colloid as a receptor directed MR contrast agent. Magn. Reson. Imag. 8, 637-646.
4. Kornguth SE, Turski PA, Perman WH, Schultz R, Kalinke T, Reale R, Raybaud F (1987) Magnetic resonance imaging of gadolinium-labeled monoclonal antibody polymers directed at human T lymphocytes implanted in canine brain. J. Neurosurg. 66, 898-906.
5. Krieg FM, Andres RY, Winterhalter KH (1995) Superparamagnetically labelled neutrophils as potential abscess-specific contrast agent for MRI. Magn. Reson. Imag. 13, 393-400.
6. Lagoutine F, Coursol N, Legrand J (1982) Table des radionucléides. Sélection Médicale, CEA, Paris.
7. Massiot P, Lizon C, Bailly I, Le Foil L, Rateau G, Frisch P (1998) Combination of energy dispersive X-ray spectrometry and autoradiography for physicochemical characterization of inhaled actinide oxide. J. Trace Microprobe Techniques 16, 183-193.
8. Pouliquen D, Le Jeune JJ, Perdrisot R, Ermias A, Jallet P (1991) Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism. Magn. Reson. Imag. 9, 275-283.
9. Rechenmann RV, Wittendorp E (1976) Some basic and pratical aspects on the development of nuclear emulsions. J. Microsc. Biol. Cell. 27, 91-100.
10. Reimer P, Weissleder R, Shen T, Knoefel WT, Brady TJ (1994) Pancreatic receptors: initial feasibility studies with a target contrast agent for MR imaging. Radiology 193, 527-531.
11. Reimer P, Weissleder R, Wittenberg J, Brady TJ (1992) Receptor-directed contrast agents for MR imaging: preclinical evaluation with affinity assays. Radiology 182, 565-569.
12. Tiefenauer LX, Kühne G, Andres RY (1993) Antibody-magnetite nanoparticles: in vivo characterization of a potential tumor-specific contrast agent for magnetic resonance imaging. Bioconjugate Chem. 4, 347-352.
13. Umezawa F, Eto Y (1988) Liposome targeting to mouse brain: mannose as a recognition marker. Biochem. Biophys. Res. Comm. 153, 1038-1044.
14. Unger EC, Totty WG, Neufeld DM, Otsuka FL, Murphy WA, Welch MS, Connett JM, Philpott GW (1985) Magnetic resonance imaging using Gadolinium labeled monoclonal antibody. Invest. Radial. 20, 693-700.
15. 22Na in biological systems. J. Trace Microprobe Techniques 12, 123-144.
16. Wittendorp-Rechenmann E, Finck M, Demangeat C (1993) High resolution autoradiographic detection of β-γ emitters in biological tissus: case of Indium-111. CR Acad. Sci. (Paris) 316, 636-641.
17. Wittendorp-Rechenmann E, Thellier M (1993) Specific methods for the imaging of radioactive tracers. Plant Physiol. Biochem. 31, 609-619.
18. Yu O, Namer IJ, Steibel J, Eclancher B, Poulet P, Chambron J (1995) Susceptibility-based MRI contrast of the CSF by intravascular superparamagnetic nanoparticles. MAGMA 3, 169-172.